» Authors » Marina Laiko

Marina Laiko

Explore the profile of Marina Laiko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 203
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen G, Gupta R, Petrik S, Laiko M, Leatherman J, Asquith J, et al.
Cancer Immunol Res . 2014 Aug; 2(10):949-61. PMID: 25116755
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting tumor vaccines are bioactive, but limited by disease burden and immune tolerance. Cyclophosphamide augments vaccine activity in tolerant neu mice and in patients with metastatic breast...
2.
Emens L, Asquith J, Leatherman J, Kobrin B, Petrik S, Laiko M, et al.
J Clin Oncol . 2009 Oct; 27(35):5911-8. PMID: 19805669
Purpose: Granulocyte-macrophage colony-stimulating factor (GM-CSF) -secreting tumor vaccines have demonstrated bioactivity but may be limited by disease burdens and immune tolerance. We tested the hypothesis that cyclophosphamide (CY) and doxorubicin...
3.
Laiko M, Murtazina R, Malyukova I, Zhu C, Boedeker E, Gutsal O, et al.
Exp Cell Res . 2009 Sep; 316(4):657-66. PMID: 19744479
Shiga toxins (Stx) 1 and 2 are responsible for intestinal and systemic sequelae of infection by enterohemorrhagic Escherichia coli (EHEC). However, the mechanisms through which enterocytes are damaged remain unclear....
4.
Maluykova I, Gutsal O, Laiko M, Kane A, Donowitz M, Kovbasnjuk O
Biochim Biophys Acta . 2008 Mar; 1782(6):370-7. PMID: 18342638
Shiga toxins (Stx), released into the intestinal lumen by enterohemorrhagic Escherichia coli (EHEC), are major virulence factors responsible for gastrointestinal and systemic illnesses. These pathologies are believed to be due...